| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 1557 |
| 1 | ADALIMUMAB | 1215 |
| 2 | METHOTREXATE SODIUM | 1031 |
| 3 | METHOTREXATE | 1012 |
| 4 | LEFLUNOMIDE | 827 |
| 5 | PREDNISONE | 664 |
| 6 | DIMETHYL FUMARATE | 649 |
| 7 | DICLOFENAC SODIUM | 641 |
| 8 | RITUXIMAB | 632 |
| 9 | ERENUMAB-AOOE | 627 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AZATHIOPRINE SODIUM | 206 | 0.0812 |
| 1 | GOLD | 414 | 0.0713 |
| 2 | NICOTINAMIDE | 175 | 0.0685 |
| 3 | MINOCYCLINE HYDROCHLORIDE | 242 | 0.0408 |
| 4 | GOLIMUMAB | 471 | 0.0374 |
| 5 | BOTULINUM TOXIN TYPE A | 320 | 0.0250 |
| 6 | CHLORHEXIDINE GLUCONATE | 223 | 0.0238 |
| 7 | HUMAN C1-ESTERASE INHIBITOR | 329 | 0.0224 |
| 8 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 135 | 0.0219 |
| 9 | MAGNESIUM CITRATE ORAL SOLUTION | 135 | 0.0219 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 2004 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1224 |
| 2 | Corticosteroid [EPC] | 1050 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 1040 |
| 4 | Antirheumatic Agent [EPC] | 828 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 694 |
| 6 | Interferon beta [EPC] | 686 |
| 7 | Phosphodiesterase 4 Inhibitor [EPC] | 591 |
| 8 | Interleukin-17A Antagonist [EPC] | 559 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 555 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 337 | 0.4898 |
| 1 | Partial Opioid Agonist/Antagonist [EPC] | 1 | 0.0208 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 114 | 0.0195 |
| 3 | Provitamin D2 Compound [EPC] | 533 | 0.0179 |
| 4 | PCSK9 Inhibitor [EPC] | 397 | 0.0154 |
| 5 | Interleukin-17A Antagonist [EPC] | 559 | 0.0150 |
| 6 | Antirheumatic Agent [EPC] | 828 | 0.0078 |
| 7 | Adrenocorticotropic Hormone [EPC] | 7 | 0.0078 |
| 8 | Endoglycosidase [EPC] | 11 | 0.0059 |
| 9 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 7 | 0.0056 |